Exploration of an alternative reconstructed individual patient data-based approach for budget impact analysis of anticancer drugs

BACKGROUND: The duration of treatment (DOT) of the initial intervention and subsequent treatment is the key to determining the accuracy of anticancer-drug budget impact analysis (BIA) calculations. However, existing studies only use simple assumptions as a proxy for DOT, resulting in a high degree o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Yue, Zhou, Jiting, Ye, Yuxin, Ma, Aixia, Li, Hongchao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259044/
https://www.ncbi.nlm.nih.gov/pubmed/37303057
http://dx.doi.org/10.1186/s12962-023-00447-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10259044/
https://www.ncbi.nlm.nih.gov/pubmed/37303057
http://dx.doi.org/10.1186/s12962-023-00447-7

Ejemplares similares